أصول متداولة تغيير تاريخ
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 35.3B 2.39B 2026-03
Essilor EUR 11.24B 770M 2026-06
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
GRIFOLS EUR 5.25B 180M 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 27.35B 744M 2026-06
Philips EUR 9.33B 454M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Smith & Nephew USD 4.63B 169M 2025-12
Sonova Holding CHF 1.91B 466.3M 2025-06
UCB EUR 6.05B 733M 2025-12